Item is a carbon copy of the agreement between the Governors of the University of Toronto and Eli Lilly and company for a foreign export license. Grants Eli Lilly and company the non-exclusive right, license, and privilege of exporting insulin to all countries of the world except the following: the United States of America and its dependencies, Canada, Great Britain, Australia, New Zealand, South Africa, India, Ceylon, Egypt, Palestine, Rhodesia North, Rhodesia South, Newfoundland, Jamaica, Switzerland, Austria, Spain, Japan, Finland, Denmark, Norway, Sweden, and Germany.